Background. Sympathetic nervous system (SNS) activation decreases fluid delivery to the Henle’s loop and response to diuretics; paradoxically, both α1-adrenoceptor agonists and sympatholytic α2-adrenoceptor agonists are recommended in the management of ascitic cirrhosis. Aims & Methods. We assessed the effects of increasing doses of clonidine (α2-agonist) vs. midodrine (α1-agonist) on renal function, mean arterial pressure (MAP), and hormonal status in rats with ascitic cirrhosis due to 13-week CCl4 administration (groups G1-G5), in comparison with control rats (Gc), rats with ascitic cirrhosis untreated (G6) or treated with daily diuretics (0.5 mg/kg furosemide plus 2 mg/kg K+-canrenoate during the 11th-13th weeks of CCl4) (G7). G1-G5 cirrhotic rats received daily, during the 11th-13th CCl4 weeks: clonidine 0.3 mcg only (G1), diuretics + clonidine 0.2 (G2), 0.5 (G3), or 1 mcg (G4), diuretics + midodrine 1 mg/kg b.w. (G5). Results. Cirrhotic rats in G1 or G2 had higher glomerular filtration rate, renal plasma flow, and natriuresis than cirrhotic rats treated with diuretics (G7) (all P<0.05). The addition of clonidine 0.2 mcg to diuretics (G2 vs. G7) reduced serum norepinephrine (169 ± 71 vs. 523 ± 88 ng/L) and plasma renin activity (12 ± 3 vs. 25 ± 5 ng/mL/h) (all P<0.05). Midodrine did not improve the renal performance in ascitic rats treated with diuretics. In comparison to absolute cirrhotic controls (G6), MAP was lower in G4 and higher in G5 (all P<0.05). Conclusions. Low-dose α2-agonists improve natriuresis and reduce SNS function and hyper-aldosteronism without affecting arterial pressure in experimental ascitic cirrhosis treated with diuretics.

Dose-dependecy of clonidine's effects in ascitic cirrhotic rats: Comparison with α1-adrenergic agonist midodrine.

ARAGNO, Manuela;MASTROCOLA, Raffaella;PAROLA, Maurizio
Last
2016-01-01

Abstract

Background. Sympathetic nervous system (SNS) activation decreases fluid delivery to the Henle’s loop and response to diuretics; paradoxically, both α1-adrenoceptor agonists and sympatholytic α2-adrenoceptor agonists are recommended in the management of ascitic cirrhosis. Aims & Methods. We assessed the effects of increasing doses of clonidine (α2-agonist) vs. midodrine (α1-agonist) on renal function, mean arterial pressure (MAP), and hormonal status in rats with ascitic cirrhosis due to 13-week CCl4 administration (groups G1-G5), in comparison with control rats (Gc), rats with ascitic cirrhosis untreated (G6) or treated with daily diuretics (0.5 mg/kg furosemide plus 2 mg/kg K+-canrenoate during the 11th-13th weeks of CCl4) (G7). G1-G5 cirrhotic rats received daily, during the 11th-13th CCl4 weeks: clonidine 0.3 mcg only (G1), diuretics + clonidine 0.2 (G2), 0.5 (G3), or 1 mcg (G4), diuretics + midodrine 1 mg/kg b.w. (G5). Results. Cirrhotic rats in G1 or G2 had higher glomerular filtration rate, renal plasma flow, and natriuresis than cirrhotic rats treated with diuretics (G7) (all P<0.05). The addition of clonidine 0.2 mcg to diuretics (G2 vs. G7) reduced serum norepinephrine (169 ± 71 vs. 523 ± 88 ng/L) and plasma renin activity (12 ± 3 vs. 25 ± 5 ng/mL/h) (all P<0.05). Midodrine did not improve the renal performance in ascitic rats treated with diuretics. In comparison to absolute cirrhotic controls (G6), MAP was lower in G4 and higher in G5 (all P<0.05). Conclusions. Low-dose α2-agonists improve natriuresis and reduce SNS function and hyper-aldosteronism without affecting arterial pressure in experimental ascitic cirrhosis treated with diuretics.
35
10
16
α-adrenoceptor agonists; experimental cirrhosis; ascites; cirrhosis complications
Sansoè, G; Aragno, M; Mastrocola, R; Parola, M2.
File in questo prodotto:
File Dimensione Formato  
Liver International 2015_4aperto.pdf

Open Access dal 23/07/2016

Descrizione: post print
Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 457.61 kB
Formato Adobe PDF
457.61 kB Adobe PDF Visualizza/Apri
Liver International 2016.pdf

Accesso riservato

Descrizione: pdf editoriale
Tipo di file: PDF EDITORIALE
Dimensione 213.39 kB
Formato Adobe PDF
213.39 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1521213
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 3
social impact